Colchicine a Case Study for What ' s Wrong With US Drug Pricing Colchicine a Case Study for What ' s Wrong With US Drug Pricing
A Medicare/Medicaid analysis shows a prolonged public-spending burden, despite generics available outside the United States for pennies a pill. Meanwhile, use widens from gout to MI, even COVID-19.Medscape Medical News
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Cardiology News Source Type: news
More News: Cardiology | Colchicine | Colcrys | COVID-19 | Drugs & Pharmacology | Gout | Heart | Medicaid | Medicare | Study | USA Health